Dexco revenue and financials

DXCO3 · B3 · BRL

Compare Dexco
R$4.67Change from previous close: −1.68%Absolute change: −R$0.08

Close · November 19, 2026

In the fiscal year ended December 2025, Dexco reported revenue of R$8.25B (+0.17% year over year). Net income was R$1.18M, a net margin of 0.0%.

Annual revenue · 2025: R$8.25B
  1. R$3.91B2016
  2. R$3.99B2017
  3. R$4.95B2018
  4. R$5.01B2019
  5. R$5.88B2020
  6. R$8.17B2021
  7. R$8.49B2022
  8. R$7.38B2023
  9. R$8.23B2024
  10. R$8.25B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+0.17%
2025 vs 2024
Net income growth
−99.31%
2025 vs 2024
Net margin
0.0%
2024: 2.1%

How Dexco is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of BRL; per-share values in BRL; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue8,2498,2357,3838,4878,1705,8805,0124,9493,9913,910
Cost of revenue6,3486,2735,7766,2135,4304,1453,8443,7993,0623,059
Gross profit1,9011,9621,6072,2742,7401,7351,1681,150929851
Selling, general and administrative1,5301,5451,4281,4591,3101,037948899801752
Operating income5244122217971,83162151322811978.7
EBIT5244122217971,83162151322811978.7
EBITDA1,6671,5351,3871,6422,5431,2421,2331,034677658
Interest expense9177771,061916306269264285264275
Pre-tax income-88.23447519181,98953547958221517.8
Income tax-151170-60.015326380.873.315130.2-8.4
Net income1.21727907561,72545440643218523.6
Net income to common shareholders1.21727907561,72545440643218523.6
Basic EPS0.000.190.870.832.220.490.430.460.200.03
Diluted EPS0.000.190.870.822.210.480.430.460.200.03
Average shares (basic)916905905915776935934934934925
Average shares (diluted)918908908918781942943942944940
Dividend per share——0.19—0.950.230.280.580.070.01

Companies in the group: same and related industries, similar size